Skip to main content
Log in

Liver stiffness by two-dimensional shear wave elastography for screening high-risk varices in patients with compensated advanced chronic liver disease

  • Ultrasound
  • Published:
European Radiology Aims and scope Submit manuscript

A Letter to the Editor to this article was published on 09 April 2024

An Author Correction to this article was published on 01 February 2024

This article has been updated

Abstract

Objectives

To investigate the usefulness of the criteria with liver stiffness (LS) measured by two-dimensional shear wave elastography (2D-SWE) and platelet count (PLT) for ruling out high-risk varices in patients with compensated advanced chronic liver disease (cACLD).

Methods

A total of 661 patients with cACLD had successfully undergone 2D-SWE and endoscopy screening. We analyzed risk factors for the presence of high-risk varices and compared proportions of patients who were spared endoscopy when used the predicting criteria with LS (ranged from 16 to 25 kPa) and PLT (ranged from 80 × 109/L to 150 × 109/L).

Results

PLT, albumin, LS were found to be independent predictors of high-risk varices. The LS values for ruling out and ruling in high-risk varices were 14.0 kPa and 24.8 kPa, respectively. When the Baveno VI criteria LS < 20 kPa and PLT > 150 × 109/L were used, the high-risk varices miss rate was 2.1%, while the saved endoscopy rate only was 19.2%. The new criteria that LS < 16 kPa and PLT > 100 × 109/L saved 30.4–34.6% endoscopy with 0–3.2% high-risk varices miss rate in the subgroup analysis stratified according to the types of underlying liver disease.

Conclusions

The Baveno VI criteria can be applied to LS measurement by 2D-SWE. The new criteria that LS < 16 kPa and PLT > 100 × 109/L could be a potential model to spare more endoscopy screening with < 5% high-risk varices miss rate.

Key Points

LS measured by 2D-SWE is reliable predictive factor for predicting all-size varices and high-risk varices in patients with compensated advanced chronic liver disease.

LS measured by 2D-SWE < 16 kPa and PLT > 100 × 109 /L, which can spare more endoscopy than Baveno VI criteria with < 5% high-risk varices miss rate.

The Baveno VI criteria can be applied to LS measurement by 2D-SWE.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

Change history

Abbreviations

2D-SWE:

Two-dimensional shear wave elastography

AIH:

Autoimmune liver disease

ALT:

Alanine aminotransferase

AST:

Aspartate aminotransferase

AUROC:

Areas under receiver operating characteristic curve

cACLD:

Compensated advanced chronic liver disease

CI:

Confidence index

CSPH:

Clinically significant portal hypertension

HVPG:

Hepatic venous pressure gradient

INR:

International normalized ratio

LS:

Liver stiffness

MELD:

Model for end-stage liver disease

NPV:

Negative predictive value

PBC:

Primary biliary cholangitis

PLT:

Platelet count

PPV:

Positive predictive value

PT:

Prothrombin time

TE:

Transient elastography

References

  1. Kim HY, So YH, Kim W et al (2019) Non-invasive response prediction in prophylactic carvedilol therapy for cirrhotic patients with esophageal varices. J Hepatol 70:412–422

    Article  CAS  PubMed  Google Scholar 

  2. de Franchis R, Baveno VIF (2015) Expanding consensus in portal hypertension: report of the Baveno VI consensus workshop: stratifying risk and individualizing care for portal hypertension. J Hepatol 63:743–752

    Article  PubMed  Google Scholar 

  3. Stafylidou M, Paschos P, Katsoula A et al (2019) Performance of Baveno VI and expanded Baveno VI criteria for excluding high-risk varices in patients with chronic liver diseases: a systematic review and meta-analysis. Clin Gastroenterol Hepatol 17:1744-1755 e1711

    Article  PubMed  Google Scholar 

  4. Colecchia A, Ravaioli F, Marasco G et al (2018) A combined model based on spleen stiffness measurement and Baveno VI criteria to rule out high-risk varices in advanced chronic liver disease. J Hepatol 69:308–317

    Article  PubMed  Google Scholar 

  5. Wong GLH, Liang LY, Kwok R et al (2019) Low risk of variceal bleeding in patients with cirrhosis after variceal screening stratified by liver/spleen stiffness. Hepatology 70:971–981

    Article  PubMed  Google Scholar 

  6. Thabut D, Bureau C, Layese R et al (2019) Validation of Baveno VI criteria for screening and surveillance of esophageal varices in patients with compensated cirrhosis and a sustained response to antiviral therapy. Gastroenterology 156:997-1009 e1005

    Article  PubMed  Google Scholar 

  7. Moctezuma-Velazquez C, Saffioti F, Tasayco-Huaman S et al (2019) Non-invasive prediction of high-risk varices in patients with primary biliary cholangitis and primary sclerosing cholangitis. Am J Gastroenterol 114:446–452

    Article  PubMed  Google Scholar 

  8. Berger A, Ravaioli F, Farcau O et al (2020) Including ratio of platelets to liver stiffness improves accuracy of screening for esophageal varices that require treatment. Clin Gastroenterol Hepatol. https://doi.org/10.1016/j.cgh.2020.06.022

    Article  PubMed  Google Scholar 

  9. Castera L, Foucher J, Bernard PH et al (2010) Pitfalls of liver stiffness measurement: a 5-year prospective study of 13,369 examinations. Hepatology 51:828–835

    PubMed  Google Scholar 

  10. Gao Y, Zheng J, Liang P et al (2018) Liver fibrosis with two-dimensional US shear-wave elastography in participants with chronic hepatitis B: a prospective multicenter study. Radiology 289:407–415

    Article  PubMed  Google Scholar 

  11. Elkrief L, Rautou PE, Ronot M et al (2015) Prospective comparison of spleen and liver stiffness by using shear-wave and transient elastography for detection of portal hypertension in cirrhosis. Radiology 275:589–598

    Article  PubMed  Google Scholar 

  12. Furlan A, Tublin ME, Yu L, Chopra KB, Lippello A, Behari J (2020) Comparison of 2D shear wave elastography, transient elastography, and MR elastography for the diagnosis of fibrosis in patients with nonalcoholic fatty liver disease. AJR Am J Roentgenol 214:W20–W26

    Article  PubMed  Google Scholar 

  13. Thiele M, Hugger MB, Kim Y et al (2020) 2D shear wave liver elastography by aixplorer to detect portal hypertension in cirrhosis: an individual patient data meta-analysis. Liver Int 40:1435–1446

    Article  PubMed  Google Scholar 

  14. Jansen C, Bogs C, Krag A, Francque S, Trebicka J (2017) Sequential shear-wave elastography of liver and spleen rules out clinically significant portal hypertension in compensated advanced chronic liver disease. Gut 66:558–559

    Article  PubMed  Google Scholar 

  15. Elkrief L, Ronot M, Andrade F et al (2018) Non-invasive evaluation of portal hypertension using shear-wave elastography: analysis of two algorithms combining liver and spleen stiffness in 191 patients with cirrhosis. Aliment Pharmacol Ther 47:621–630

    Article  CAS  PubMed  Google Scholar 

  16. Kim TY, Kim TY, Kim Y, Lim S, Jeong WK, Sohn JH (2016) Diagnostic performance of shear wave elastography for predicting esophageal varices in patients with compensated liver cirrhosis. J Ultrasound Med 35:1373–1381

    Article  PubMed  Google Scholar 

  17. Yoo HW, Kim YS, Kim SG et al (2019) Usefulness of noninvasive methods including assessment of liver stiffness by 2-dimensional shear wave elastography for predicting esophageal varices. Dig Liver Dis 51:1706–1712

    Article  PubMed  Google Scholar 

  18. Petzold G, Tsaknakis B, Bremer SCB et al (2019) Evaluation of liver stiffness by 2D-SWE in combination with non-invasive parameters as predictors for esophageal varices in patients with advanced chronic liver disease. Scand J Gastroenterol 54:342–349

    Article  PubMed  Google Scholar 

  19. European Association for the Study of the Liver (2021) Easl clinical practice guidelines (Cpgs) on non-invasive tests for evaluation of liver disease severity and prognosis-2020 Update. J Hepatol. https://doi.org/10.1016/j.jhep.2021.05.025

  20. Cassinotto C, Lapuyade B, Guiu B et al (2020) Agreement between 2-dimensional shear wave and transient elastography values for diagnosis of advanced chronic liver disease. Clin Gastroenterol Hepatol. https://doi.org/10.1016/j.cgh.2020.04.034

    Article  PubMed  Google Scholar 

  21. Herrmann E, de Ledinghen V, Cassinotto C et al (2018) Assessment of biopsy-proven liver fibrosis by two-dimensional shear wave elastography: an individual patient data-based meta-analysis. Hepatology 67:260–272

    Article  CAS  PubMed  Google Scholar 

  22. Grgurevic I, Puljiz Z, Brnic D et al (2015) Liver and spleen stiffness and their ratio assessed by real-time two dimensional-shear wave elastography in patients with liver fibrosis and cirrhosis due to chronic viral hepatitis. Eur Radiol 25:3214–3221

    Article  PubMed  Google Scholar 

  23. Furlan A, Tublin ME, Yu L, Chopra KB, Lippello A, Behari J (2020) Comparison of 2D shear wave elastography, transient elastography, and mr elastography for the diagnosis of fibrosis in patients with nonalcoholic fatty liver disease. AJR Am J Roentgenol 214:W20–W26

  24. Zeng J, Zheng J, Huang ZP et al (2017) Comparison of 2-D shear wave elastography and transient elastography for assessing liver fibrosis in chronic hepatitis B. Ultrasound Med Biol 43:1563–1570

    Article  PubMed  Google Scholar 

  25. Ferraioli G, Wong VW, Castera L et al (2018) Liver ultrasound elastography: an update to the world federation for ultrasound in medicine and biology guidelines and recommendations. Ultrasound Med Biol 44:2419–2440

    Article  PubMed  Google Scholar 

  26. Wang CZ, Zheng J, Huang ZP et al (2014) Influence of measurement depth on the stiffness assessment of healthy liver with real-time shear wave elastography. Ultrasound Med Biol 40:461–469

    Article  PubMed  Google Scholar 

  27. Calvaruso V, Cacciola I, Licata A et al (2019) Is transient elastography needed for noninvasive assessment of high-risk varices? The REAL Experience. Am J Gastroenterol 114:1275–1282

    Article  PubMed  Google Scholar 

  28. Kew GS, Chen ZJ, Yip AW et al (2021) Identifying patients with cirrhosis who might avoid screening endoscopy based on serum albumin and bilirubin and platelet counts. Clin Gastroenterol Hepatol 19:199

    Article  PubMed  Google Scholar 

  29. Yu JB, Xiong H, Yuan XC, Zhou AY (2019) Liver stiffness detected by shear wave elastography predicts esophageal varices in cirrhotic patients. Ultrasound Q. https://doi.org/10.1097/RUQ.0000000000000466

    Article  PubMed  Google Scholar 

  30. Kang SH, Baik SK, Kim MY (2020) Application of Baveno criteria and modified baveno criteria with shear-wave elastography in compensated advanced chronic liver disease. J Korean Med Sci 35:e249

    Article  PubMed  PubMed Central  Google Scholar 

  31. Cho YS, Kim Y, Sohn JH (2020) Application of supersonic shear imaging to the Baveno VI criteria and a combination model with spleen stiffness measurement to rule out high-risk varices in compensated advanced chronic liver disease. Ultraschall Med. https://doi.org/10.1055/a-1168-6271

    Article  PubMed  Google Scholar 

  32. Suh CH, Kim KW, Park SH et al (2018) Shear wave elastography as a quantitative biomarker of clinically significant portal hypertension: a systematic review and meta-analysis. AJR Am J Roentgenol 210:W185–W195

    Article  PubMed  Google Scholar 

  33. Gaete MI, Diaz LA, Arenas A et al (2020) Baveno VI and expanded Baveno VI criteria successfully predicts the absence of high-risk gastro-oesophageal varices in a Chilean cohort. Liver Int 40:1427–1434

    Article  PubMed  Google Scholar 

  34. Petta S, Sebastiani G, Bugianesi E et al (2018) Non-invasive prediction of esophageal varices by stiffness and platelet in non-alcoholic fatty liver disease cirrhosis. J Hepatol 69:878–885

    Article  PubMed  Google Scholar 

  35. Augustin S, Pons M, Maurice JB et al (2017) Expanding the Baveno VI criteria for the screening of varices in patients with compensated advanced chronic liver disease. Hepatology 66:1980–1988

    Article  PubMed  Google Scholar 

  36. Wang H, Wen B, Chang X et al (2021) Baveno VI criteria and spleen stiffness measurement rule out high-risk varices in virally suppressed HBV-related cirrhosis. J Hepatol 74:584–592

    Article  PubMed  Google Scholar 

  37. Berger A, Ravaioli F, Farcau O et al (2021) Including ratio of platelets to liver stiffness improves accuracy of screening for esophageal varices that require treatment. Clin Gastroenterol Hepatol 19:777-787 e717

    Article  PubMed  Google Scholar 

  38. Ikeda F, Okamoto R, Baba N et al (2012) Prevalence and associated factors with esophageal varices in early primary biliary cirrhosis. J Gastroenterol Hepatol 27:1320–1328

    Article  CAS  PubMed  Google Scholar 

  39. Ali AH, Sinakos E, Silveira MG, Jorgensen RA, Angulo P, Lindor KD (2011) Varices in early histological stage primary biliary cirrhosis. J Clin Gastroenterol 45:e66-71

    Article  PubMed  Google Scholar 

  40. Lee HA, Kim SU, Seo YS et al (2019) Prediction of the varices needing treatment with non-invasive tests in patients with compensated advanced chronic liver disease. Liver Int 39:1071–1079

    Article  PubMed  Google Scholar 

  41. Kew G, Chen Z, Yip A et al (2021) Identifying patients with cirrhosis who might avoid screening endoscopy based on serum albumin and bilirubin and platelet counts. Clin Gastroenterol Hepatol 19:199-201.e192

    Article  PubMed  Google Scholar 

  42. Dong T, Kalani A, Aby E et al (2019) Machine learning-based development and validation of a scoring system for screening high-risk esophageal varices. Clin Gastroenterol Hepatol 17:1894-1901.e1891

    Article  PubMed  Google Scholar 

  43. Kotwal V, Mbachi C, Wang Y et al (2020) A novel score to predict esophageal varices in patients with compensated advanced chronic liver disease. Dig Dis Sci. https://doi.org/10.1007/s10620-020-06456-3

    Article  PubMed  Google Scholar 

  44. Jangouk P, Turco L, De Oliveira A, Schepis F, Villa E, Garcia-Tsao G (2017) Validating, deconstructing and refining Baveno criteria for ruling out high-risk varices in patients with compensated cirrhosis. Liver Int 37:1177–1183

    Article  PubMed  PubMed Central  Google Scholar 

Download references

Funding

This study has received funding: Post-Doctor Research Project, West China Hospital, Sichuan University (No. 2019HXBH045) and China Postdoctoral Science Foundation (No. 2020M673263).

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Li Yang.

Ethics declarations

Guarantor

The scientific guarantor of this publication is Li Yang.

Conflict of interest

The authors declare no competing interests.

Statistics and biometry

No complex statistical methods were necessary for this paper.

Informed consent

Written informed consent was waived by the institutional review board.

Ethical approval

Institutional review board approval was obtained.

Methodology

• retrospective.

• diagnostic and prognostic study.

• performed at one institution.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

The original online version of this article was revised: Some results in Table 3 Section "High-risk varices" row "Rule in" were incorrect. The correct Table 3 is as follows. The revised entries have been emphasized for purposes of clarity: Rule in24.836.1%95.1%75.0%78.5%78.1%

Supplementary Information

Below is the link to the electronic supplementary material.

Supplementary file1 (DOCX 24 KB)

Rights and permissions

Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Yan, Y., Xing, X., Wang, X. et al. Liver stiffness by two-dimensional shear wave elastography for screening high-risk varices in patients with compensated advanced chronic liver disease. Eur Radiol 32, 2078–2088 (2022). https://doi.org/10.1007/s00330-021-08280-3

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00330-021-08280-3

Keywords

Navigation